首页> 外文OA文献 >A Survey of the Regulatory Requirements for the Waiver of In Vivo Bioequivalence Studies of Generic Products in Certain Dosage Forms by Participating Regulators and Organisations of the International Pharmaceutical Regulators Programme

【2h】

A Survey of the Regulatory Requirements for the Waiver of In Vivo Bioequivalence Studies of Generic Products in Certain Dosage Forms by Participating Regulators and Organisations of the International Pharmaceutical Regulators Programme

机译：参与监管机构和国际制药监管机构方案的某些用量形式缩小普通产品体内生物等效研究的监管要求调查

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Alfredo Garcia Arieta; Craig Simon; Andrew Tam; Gustavo Mendes Lima Santos; Eduardo Agostinho Freitas Fernandes; Zulema Rodríguez Martínez; Clare Rodrigues; Sang Aeh Park; JaYoung Kim; Kwansoo Kim; Ryosuke Kuribayashi; Aya Myoenzono; Kohei Shimojo; Chantal Walther; Matthias S. Roost; Wen-Yi Hung; Li-feng Hsu; Christopher Crane; April C. Braddy; Joy Van Oudtshoorn; Diego Alejandro Gutierrez Triana; Erwin Guzmán Aurela; Ben Jones; Henrike Potthast; Ivana Abalos;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. A Survey of the Regulatory Requirements for BCS-Based Biowaivers for Solid Oral Dosage Forms by Participating Regulators and Organisations of the International Generic Drug Regulators Programme [J] . Joy Elizabeth van Oudtshoorn, Alfredo García-Arieta, Gustavo Mendes Lima Santos, Journal of Pharmacy and Pharmaceutical Sciences . 2018,第1期

机译：参与监管者和国际仿制药监管者组织对基于BCS的固体口服剂型生物豁免的监管要求的调查
2. The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities [J] . Christopher Crane, Gustavo Mendes Lima Santos, Eduardo Agostinho Freitas Fernandes, Journal of Pharmacy and Pharmaceutical Sciences . 2019,第3期

机译：在国际制药监管机构方案参与监管机构和组织中立即释放固体口服剂型的额外强度生物应用的要求：差异和常见
3. An IPRP survey of the regulatory requirements for the waiver of in vivo bioequivalence studies of generic medicinal products in certain dosage forms [J] . Alfredo García Arieta, Clare Rodrigues GaBi journal. . 2021,第3期

机译：对某些剂型普通药用产品的豁免豁免的监管要求的IPRP调查
4. Combining Balanced Scorecard and Data Envelopment Analysis to Design Performance Measurement for Supply Chain Actor and Regulator: A Case Study in Innovative Product in Indonesia [C] . Elisa kusrini, Subagyo, Nur Aini Masruroh Industrial Engineering, Management Science and Applications 2015 . 2015

机译：结合平衡计分卡和数据包络分析进行供应链参与者和监管者的设计绩效评估：以印度尼西亚创新产品为例
5. Survey of International Regulatory Bioequivalence Recommendations for Approval of Generic Topical Dermatological Drug Products [O] . April C. Braddy, Barbara M. Davit, Ethan M. Stier, 2015

机译：批准国际常规皮肤用皮肤病药品国际法规生物等效性建议书的调查
6. A Survey of the Regulatory Requirements for the Acceptance of Foreign Comparator Products by Participating Regulators and Organizations of the International Generic Drug Regulators Programme [O] . Alfredo Garcia Arieta, Craig Simon, Gustavo Mendes Lima Santos, 2019

机译：通过参与监管机构和国际通用药物监管机构的组织接受外国比较产品的监管要求调查

A Survey of the Regulatory Requirements for the Waiver of In Vivo Bioequivalence Studies of Generic Products in Certain Dosage Forms by Participating Regulators and Organisations of the International Pharmaceutical Regulators Programme

著录项

相似文献

相关主题

期刊订阅